IGIL vs SICAGEN: Stock Comparison

INTL GEMOLOGICAL INST vs SICAGEN INDIAUpdated 15 Sept 26, 1:58 PM ISTNSE & company filings

INTL GEMOLOGICAL INST is the larger company by market capitalisation. INTL GEMOLOGICAL INST shows a higher ROE, faster revenue growth and lower leverage, while SICAGEN INDIA shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

IGIL leads 7; SICAGEN leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

IGILSICAGEN

Valuation lens

What price are you paying?

Market CapContext only
₹13,609 Cr
₹221 Cr
P/E RatioSICAGEN has the lower reading
29.64x
11.41x
P/B RatioSICAGEN has the lower reading
9.18x
0.47x
EPSSICAGEN has the higher reading
₹0.38
₹1.75
Book ValueContext only
₹32.62
₹125.09
Dividend YieldSICAGEN has the higher reading
1.6%
3.74%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
IGIL is the larger company
₹13,609 Cr vs ₹221 Cr
P/E Ratio
SICAGEN has a lower P/E
11.41x vs 29.64x
P/B Ratio
SICAGEN has a lower P/B
0.47x vs 9.18x
EPS
SICAGEN has higher earnings per share
₹1.75 vs ₹0.38
Dividend Yield
SICAGEN has a higher dividend yield
3.74% vs 1.6%
Revenue Growth (TTM YoY)
IGIL has faster revenue growth
20.9% vs 0%
EPS Growth (TTM YoY)
IGIL has faster EPS growth
28.4% vs 0%
Qtr Sales Growth
SICAGEN has stronger quarterly sales growth
115.12% vs -87.04%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricIGILSICAGEN
SectorServices
IndustryDiversified Commercial Services

Price

MetricIGILSICAGEN
Live Price₹314.3₹53.53
Day Change0%0%
Volume3.67 L11,253
52-Week High₹392₹74.06
52-Week Low₹287₹46.55
Distance from 52W High-19.82%-27.72%

Valuation

MetricIGILSICAGEN
Market Cap₹13,609 Cr₹221 Cr
P/E Ratio29.64x11.41x
P/B Ratio9.18x0.47x
EPS₹0.38₹1.75
Book Value₹32.62₹125.09
Dividend Yield1.6%3.74%

Growth

MetricIGILSICAGEN
Revenue Growth (TTM YoY)20.9%0%
EPS Growth (TTM YoY)28.4%0%
Qtr Sales Growth-87.04%115.12%
Qtr Profit Growth-89.28%26.46%

Profitability & Leverage

MetricIGILSICAGEN
ROE40.47%3.07%
ROCE45.18%4.15%
Net Margin46.09%1.86%
Operating Margin60.87%4.48%
Debt to Equity0x0.13x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricIGILSICAGEN
Promoter Holding23.92%
FII Holding9.49% 0.89 pp2.47%
DII Holding5.51% 0.87 pp0.58%
Public Holding8.45% 0.01 pp35.81%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: INTL GEMOLOGICAL INST and SICAGEN INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.